Bio-Rad Announces Fall Web Seminar Series
Bio-Rad Laboratories, Inc. announced today a series of web seminars October through December of 2005 on spectroscopy, in silico lead optimization, ADME/Tox, and free software for teaching chemistry. Registration for these seminars is offered free of charge at http://bio-radevents.webex.com . Topics are as follows.
Spectroscopy
• Using Multiple Spectral Techniques to Optimize Spectral Search Results
• Steps to Creating a Company Resource for NMR, MS, IR, or Raman Data
• Basic & Advanced Search Strategies for Infrared
ADME/Tox & Medicinal Chemistry
• In Silico ADME Tox Prediction for Multiple Properties with Higher Accuracy
• MedChem Tools for In Silico Lead Optimization, Enumeration of Libraries, Spectral Analysis, Data Management
• Building Predictive Models for CYP Inhibition, hERG channel blocking, and ADME/Tox properties
Teaching Chemistry
• Free Chemistry & Spectroscopy Software Tools to Help Students in General, Organic, and Analytical Chemistry
Each seminar runs for about 30 minutes and is followed by a Q&A session. You can view abstracts and sign up at http://bio-radevents.webex.com/
About Bio-Rad Laboratories, Informatics Division
Bio-Rad’s Informatics Division ( http://www.informatics.bio-rad.com ) specializes in state-of-the-art software and database solutions for the pharmaceutical, biotech and chemical industries. Bio-Rad is the leading publisher of fully verified spectral databases, cheminformatics, spectroscopy software, and decision support systems for drug discovery. The company’s award-winning KnowItAll Informatics System offers a fully integrated environment with flexible, expandable software and database solutions for spectroscopy (MS, NMR, IR, Raman, and spectral data management), cheminformatics, and ADME/Tox prediction.
Bio-Rad Laboratories, Inc. ( http://www.bio-rad.com ) is a multinational manufacturer and distributor of life science research, clinical diagnostics, and informatics products. It is based in Hercules, California, and serves more than 70,000 research and industry customers worldwide through a network of more than 30 wholly owned subsidiary offices.
Various statements made within this press release may constitute “forward-looking statements” for purposes of the Securities and Exchange Commission’s “safe harbor” provisions under the Private Securities Litigation Reform Act of 1995 and Rule 3b-6 under the Securities Exchange Act of 1934. The forward-looking statements contained herein involve risks and uncertainties that could cause results to differ materially from the Company’s expectations.
